Vanta Bioscience Ltd. benchmarking: Performance to industry peers

Financial

	Vanta Bioscience	FGP	Sterling Internl.Ent
Operational Metrics
Financials
5 yr Average ROE	0.45 %	6.38 %	n/a
5yr average Equity Multiplier	5.0	1.09	n/a
5yr Average Asset Turnover Ratio	0.09	0.05	n/a
5yr Avg Net Profit Margin	-72.95 %	61.47 %	n/a
Price to Book	0.0	3.27	n/a
P/E	0.0	56.01	n/a
5yr Avg Cash Conversion Cycle	391.21 Days	0.0	n/a
Inventory Days	550.05 Days	0.0	n/a
Days Receivable	524.58 Days	0.0	n/a
Days Payable	1235.82 Days	415.0 Days	n/a
5yr Average Interest Coverage Ratio	-0.2	-1325.47	n/a
5yr Avg ROCE	-3.41 %	-3.44 %	n/a
5yr Avg Operating Profit Margin	-33.08 %	-329.83 %	n/a
5 yr average Debt to Equity	3.47	0.0	n/a
5yr CAGR Net Profit	n/a	n/a	n/a
5yr Average Return on Assets	-3.03 %	1.08 %	n/a
Shareholdings
Promoter Holding	72.81 %	42.69 %	n/a
Share Pledged by Promoters	0.0	0.0	n/a
Change in Promoter Holding (3 Yrs)	2.88 %	1.24 %	n/a
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	n/a

	Vanta Bioscience	FGP	Sterling Internl.Ent
Product Wise Break-Up	Product Wise Break-Up Others 100	Product Wise Break-Up Others 100	-
Location Wise Break-Up	Location Wise Break-Up Others 100	-	-